The Food and Drug Administration has not evaluated these statements. This product is not designed to diagnose, treat, cure, or prevent any medical condition. Not intended for human consumption.
KLOW BLEND is a multi-peptide research formulation containing GHK-Cu, BPC-157, TB-500, and KPV, intended for studies involving tissue-model regeneration, cellular-signaling pathways, and inflammatory-response modulation. GHK-Cu is a copper-binding tripeptide examined for its involvement in gene-expression dynamics and wound-model processes. BPC-157 and TB-500 are investigated for their influence on angiogenesis, fibroblast activity, and cytoskeletal regulation. KPV, a tripeptide derived from the C-terminal sequence of α-MSH, is studied for its effects on inflammatory-signaling pathways and melanocortin-receptor interactions.
Image 1 of 1